This NDC is on FDA's drug shortage list (posted Nov 3, 2017)
Reported reason: Demand increase for the drug
Product Information
MORPHINE SULFATE 10 MG/ML VIAL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $2.3422 per ML under NDC 00641612725. Its NADAC has been published 246 times since May 18, 2016.
FDA first approved this application on May 21, 2015. Its Orange Book therapeutic-equivalence code is AP.
Strength
10 mg/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00641612725
Classification
Generic
Dosage Form
INJECTION
Route
INTRAVENOUS
Effective Date
8/19/2026
Active Ingredients
MORPHINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA205758FDA Approved
5/21/2015
TE Code
AP
On Market Since
6/3/2015
Pharmacological Classes
Price Statistics
The NADAC for MORPHINE SULFATE 10 MG/ML VIAL has been published 246 times since May 18, 2016, and over the history we have for it it has risen 134.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.3422 per ML |
|---|---|
| All-time high | $2.3707 (Jul 10, 2024) |
| All-time low | $0.9983 (May 18, 2016) |
| 52-week high | $2.3466 |
| 52-week low | $2.2734 |
| Median price | $2.2795 |
| Average price | $1.9346 |
| Largest weekly change | +98.2% (Jun 17, 2020) |
| Weeks tracked | 246 |
| Tracking since | May 18, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Morphine Sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Morphine Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MORPHINE SULFATE 10 MG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for MORPHINE SULFATE 10 MG/ML VIAL, manufactured by Hikma Pharmaceuticals USA Inc., is $2.3422 per ML (NDC 00641612725), effective Sep 30, 2026.
How has the price of MORPHINE SULFATE 10 MG/ML VIAL changed over time?
Over the history we have for it, the NADAC for MORPHINE SULFATE 10 MG/ML VIAL has risen 134.6%. It has been tracked across 246 weekly CMS publications since May 18, 2016.
What are the highest and lowest recorded NADAC prices for MORPHINE SULFATE 10 MG/ML VIAL?
Since May 18, 2016, the NADAC for MORPHINE SULFATE 10 MG/ML VIAL has ranged from a low of $0.9983 (May 18, 2016) to a high of $2.3707 (Jul 10, 2024), with a median of $2.2795 per ML.
Are there cheaper alternatives to MORPHINE SULFATE 10 MG/ML VIAL?
No other NADAC-published product currently shares the active ingredient and strength of MORPHINE SULFATE 10 MG/ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MORPHINE SULFATE 10 MG/ML VIAL?
MORPHINE SULFATE 10 MG/ML VIAL (NDC 00641612725) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Is MORPHINE SULFATE 10 MG/ML VIAL in shortage?
Yes — NDC 00641612725 is currently listed in FDA's drug shortage database (posted Nov 3, 2017). Reported reason: Demand increase for the drug.